Bioethics Blogs

A Special Event Reprise: Exploring the Ethics of Cognitive Enhancement and the University’s Policy at Emory

Last month, Emory’s Committee on Academic Integrity and the Barkley Forum collaborated to host “Study Drugs: Exploring the Ethics of Cognitive Enhancement and the University’s Policy.” The program featured a debate among four Emory University undergraduates and a discussion between Emory Center for Ethics’s very own Dr. Karen Rommelfanger and Dr. John Banja in addition to Willie Bannister, Emory’s Associate Director of Health Promotion. This event, organized by Emory University senior Grant Schleifer, brought out students from many areas of study to weigh in on how the university can better address the potential issue of increasing usage of cognitive enhancement drugs within Emory’s student body.

In an effort to relay the contents of the event to the greater student body, the speeches from the event are displayed below in the order of their presentation. This 20-minute debate included two affirmative speeches advocating that Emory ought to take a stance on the use of cognitive enhancement drugs and set up a regulatory regime to oversee students’ use of cognitive enhancers.  The negative team argued against this approach to the “study drugs” problem by presenting potential negative consequences to greater monitoring of the intake of cognitive enhancers, such as creating a larger black market for drugs like Adderall.

Further, Dr. Jason Ciejka, Emory’s Associate Director of the Honor Council attended this event and provided us with a wonderful commentary on the proceedings. Given his role at the university, his perspective on issues such as cognitive enhancement is incredibly valuable and aids in further understanding the intersection of ethics and policy at the university level.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.